grant

Mechanistic and neuroanatomic bases of disparity between arm capacity and use in stroke

Organization ALBERT EINSTEIN HEALTHCARE NETWORKLocation PHILADELPHIA, UNITED STATESPosted 1 Aug 2022Deadline 31 May 2027
NIHUS FederalResearch GrantFY20253-D3-Dimensional3DAdoptedAffectAffectiveAgeApoplexyAreaAssessment instrumentAssessment toolAttentionBehavioralBehavioral MechanismsBiological MarkersBrainBrain Nervous SystemBrain Vascular AccidentBurden on their caregiversCaregiver BurdenCerebral StrokeCerebrovascular ApoplexyCerebrovascular StrokeClassificationClinicalClinical EvaluationClinical TestingClinical TreatmentCognitiveDataData AnalysesData AnalysisDetectionDiseaseDisorderDisparitiesDisparityEncephalonExhibitsExtremitiesFunctional MRIFunctional Magnetic Resonance ImagingGrantHomeIndividualInvestigationInvestigatorsKnowledgeLeftLifeLimb structureLimbsLinear ModelsMeasuresMechanisms of Behavior and Behavior ChangeMembrum superiusMethodsModelingModificationMonitorMotivationMotorMovementMuscle ParesisMuscular ParesisNeuranatomiesNeuranatomyNeuro rehabilitationNeuroanatomiesNeuroanatomyNeuropsychologic TestsNeuropsychological TestsNeuropsychologiesNeuropsychologyNeurorehabilitationNeurosciencesNon-TrunkParesisPredictive FactorPrevalencePropertyPsychometricsQOLQuality of lifeRandomized, Controlled TrialsReality TestingResearchResearch PersonnelResearchersRestRewardsRiskRunningSamplingSensorySeveritiesStrokeSyndromeSystematicsTestingTrainingUpper ExtremityUpper LimbWorkadverse consequenceadverse outcomeagesarmbasebasesbehavior mechanismbio-markersbiologic markerbiomarkerbody movementbrain attackburden in caregiversburden of their caregiversburden on caregiverscerebral vascular accidentcerebrovascular accidentchronic strokeclinical interventionclinical testclinical therapyclinical validationdata interpretationdesigndesigningdevelop therapydisabilityexperiencefMRIhomesimaging biomarkerimaging markerimaging-based biological markerimaging-based biomarkerimaging-based markerimprovedintervention developmentknowledge baseneural imagingneuro-imagingneuroimagingneurological imagingneurological rehabneurological rehabilitationneuropsychologicneurorehabneurorehabilitativenovelpareticparetic musclepsychologicpsychologicalrandomized control trialresearch clinical testingstroke patientstroke survivorstrokedstrokestargeted drug therapytargeted drug treatmentstargeted therapeutictargeted therapeutic agentstargeted therapytargeted treatmenttherapy developmentthree dimensionaltranslational pipelinetranslational spectrumtreatment developmenttrial regimentrial treatmentvirtual reality
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Project Summary
More than 750,000 individuals in the U.S. have a stroke each year, and as many as 94% of stroke survivors

exhibit reduced use of one arm, with adverse consequences for disability, caregiver burden, and quality of life.

Approximately 40%-80% of individuals who fail to use the affected arm in daily life possess adequate sensory-

motor capacity to do so. The disparity between arm use and capacity (i.e., Use/Capacity Disparity -- UCD)

occurs across a broad spectrum of sensory-motor severity and is a perplexing and urgent problem in neuro-

rehabilitation. Perhaps in part because UCD lies at the interface of sensory-motor processing and

cognitive/affective phenomena, no past research has assessed its underlying mechanisms or neuroanatomic

biomarkers. Given its prevalence, an understanding of the mechanisms of UCD across a range of severity is

required to develop targeted treatments to ameliorate the disorder. Moreover, individuals with stroke are

rarely assessed for the presence of UCD, in part because such assessment is challenging. The proposed research

will address these gaps in our knowledge and capacity by testing the predictions of 3 hypotheses of the

mechanisms underlying UCD: the sensorimotor, attention, and apathy/motivation accounts. In Aim 1 we will

administer a targeted battery of sensorimotor and neuropsychological tests to test the predictions of each of the

3 hypotheses in a sample of 100 mild to moderate left- and right-hemisphere chronic stroke patients. We will

determine the association of these measures as well as demographic and stroke-related variables with UCD.

Aim 2 will use advanced neuroimaging methods with data from resting-state functional magnetic resonance

imaging to develop imaging biomarkers associated with UCD. In Aim 3 we will validate a novel virtual reality

assessment tool to rapidly and reliably evaluate UCD. In addition to its clinical utility, the task enables built-in

assessment of the attention hypothesis by determining whether UCD is influenced by attentional task

demands. By the end of the grant period, we will have determined the demographic, sensorimotor,

neuropsychological, and neuroanatomical factors that predict UCD and validated a clinically-useful VR

assessment tool. Given the limited knowledge base in this area, this comprehensive research will pave the way

for development of treatments targeted to underlying mechanisms and enhanced identification of at-risk

individuals.

Grant Number: 5R01HD104637-04
NIH Institute/Center: NIH

Principal Investigator: LAUREL BUXBAUM

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →